Navina vs RAAPID (2026)
Two products that read the chart to find what has not been documented, and they differ in what they are optimising for. Navina assembles a consolidated patient portrait at the point of care from the record, exchanges, claims and care gap files, surfacing suspected conditions with evidence attached inside the appointment. RAAPID is built around risk adjustment specifically, with a neuro symbolic architecture linking every suggested condition code to particular clinical evidence, which turns explainability into a structural property rather than a promise, and coder validation sits inside the workflow. For a clinician facing product, Navina fits the visit. For a coding operation that has to defend every added condition in an audit, RAAPID's evidence linkage is the stronger answer. Neither publishes whether it removes codes as readily as it adds them.
- It assembles a consolidated patient portrait at the point of care from the record, exchanges, claims and care gap files, with the evidence attached to every insight.
- Named and typed certifications plus native bidirectional integration mean the insight reaches the clinician inside the appointment rather than in a worklist afterwards.
- For a group under risk, working the whole panel through the visit is broader than a coding architecture.
- The explainability architecture is the product: every suggested hierarchical condition category code links back to specific clinical evidence, which is a structural answer rather than a policy.
- Coder validation is built into the workflow and the company is unusually precise about what it controls, with both major credentials held.
- The deployment disclosure is the strongest encountered in this part of the index, which matters for a platform reading whole charts.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Navina and RAAPID are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Navina | RAAPID |
|---|---|---|
| Primary category | Clinical Decision Support | Value Based Care Intelligence |
| Founded | 2018 | 2022 |
| Headquarters | New York, New York, United States | Louisville, Kentucky, United States |
| Website | navina.ai | raapidinc.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Navina its top capability grade on AI Centrality, Autonomy and Oversight Model and EHR and Interoperability Depth. Set against RAAPID, Navina grades higher on Autonomy and Oversight Model, Clinical and Operational Evidence and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards RAAPID its top capability grade on AI Centrality and Deployment Model and Data Residency. Set against Navina, RAAPID grades higher on FDA and Regulatory Status, Deployment Model and Data Residency and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Navina or RAAPID?
On the axes where the AI Health Index separates them, Navina grades higher on Autonomy and Oversight Model, Clinical and Operational Evidence and EHR and Interoperability Depth, and RAAPID grades higher on FDA and Regulatory Status, Deployment Model and Data Residency and Commercial Transparency. Neither leads on the greater share of scored axes, so the decision turns on which constraint is binding rather than on an overall winner.
Where do Navina and RAAPID differ most?
The widest separation the AI Health Index records between Navina and RAAPID is on EHR and Interoperability Depth, where Navina grades A and RAAPID grades C. That axis sits in the Integration and Deployment group, so it should carry the most weight for a buyer whose binding constraint is how the product lands in the stack already in place.
Where do Navina and RAAPID grade the same?
The AI Health Index grades Navina and RAAPID the same on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Autonomous Medical Coding page.
Both surface conditions that improve documentation completeness and raise risk adjusted revenue at the same time, and neither publishes the two way number: what proportion of surfaced conditions clinicians confirm, and whether the system flags codes lacking documentation for removal as readily as it suggests additions. RAAPID's evidence is specific and quantified but entirely vendor reported with no independent validation located. Navina publishes no hosting, residency detail or governance framework. Neither publishes a subgroup analysis.